| (+)-catechin | increases phosphorylation | ISO | RGD:732757 | 6480464 | Catechin results in increased phosphorylation of PTK2 protein | CTD | PMID:16038899 |
| (+)-pilocarpine | multiple interactions | ISO | RGD:732757 | 6480464 | [Pilocarpine co-treated with wortmannin] results in increased phosphorylation of PTK2 protein | CTD | PMID:10537051 |
| (+)-pilocarpine | increases phosphorylation | ISO | RGD:732757 | 6480464 | Pilocarpine results in increased phosphorylation of PTK2 protein | CTD | PMID:10537051 |
| (-)-epigallocatechin 3-gallate | decreases phosphorylation | EXP | | 6480464 | epigallocatechin gallate results in decreased phosphorylation of PTK2 protein | CTD | PMID:11746506 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:732757 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PTK2 mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of PTK2 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PTK2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases phosphorylation | ISO | RGD:732757 | 6480464 | Estradiol results in increased phosphorylation of PTK2 protein | CTD | PMID:12421874 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PTK2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PTK2 mRNA | CTD | PMID:21570461 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:3443 | 6480464 | 2,4-dinitrotoluene affects the expression of PTK2 mRNA | CTD | PMID:21346803 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | ISO | RGD:3443 | 6480464 | Puromycin Aminonucleoside results in increased expression of and results in increased phosphorylation of PTK2 protein | CTD | PMID:14559718 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PTK2 mRNA | CTD | PMID:20188158 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:732757 | 6480464 | alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased phosphorylation of PTK2 protein] | CTD | PMID:16359657 |
| 3-methylcholanthrene | decreases phosphorylation | ISO | RGD:732757 | 6480464 | Methylcholanthrene results in decreased phosphorylation of PTK2 protein | CTD | PMID:16359657 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:3443 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of PTK2 mRNA | CTD | PMID:19162173 |
| 4-hydroxycoumarin | decreases phosphorylation | EXP | | 6480464 | 4-hydroxycoumarin results in decreased phosphorylation of PTK2 protein | CTD | PMID:18492274 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:732757 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of PTK2 mRNA | CTD | PMID:12419474 |
| 5-fluorouracil | decreases response to substance | ISO | RGD:732757 | 6480464 | PTK2 protein results in decreased susceptibility to Fluorouracil | CTD | PMID:16179862 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [HU 211 results in increased phosphorylation of PTK2 protein] | CTD | PMID:12163181 |
| acrylamide | increases phosphorylation | ISO | RGD:732757 | 6480464 | Acrylamide results in increased phosphorylation of PTK2 protein | CTD | PMID:11478917 PMID:18215454 |
| acrylamide | increases phosphorylation | ISO | RGD:732757 | 6480464 | Acrylamide results in increased phosphorylation of PTK2 protein | CTD | PMID:18215454 PMID:11478917 |
| acrylamide | decreases phosphorylation | ISO | RGD:732757 | 6480464 | Acrylamide results in decreased phosphorylation of PTK2 protein | CTD | PMID:18215454 |
| acrylamide | multiple interactions | ISO | RGD:732757 | 6480464 | 2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole inhibits the reaction [Acrylamide results in increased phosphorylation of PTK2 protein] | CTD | PMID:11478917 |
| actinomycin D | decreases expression | ISO | RGD:3443 | 6480464 | Dactinomycin results in decreased expression of PTK2 protein | CTD | PMID:15959627 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:732757 | 6480464 | PTK2 protein inhibits the reaction [Tretinoin promotes the reaction [CEBPA protein binds to RB1 protein]]; more ... | CTD | PMID:16226872 |
| all-trans-retinoic acid | increases expression | ISO | RGD:732757 | 6480464 | Tretinoin results in increased expression of PTK2 mRNA | CTD | PMID:17045167 |
| all-trans-retinoic acid | increases cleavage | ISO | RGD:732757 | 6480464 | Tretinoin results in increased cleavage of PTK2 protein | CTD | PMID:11369141 |
| all-trans-retinoic acid | decreases response to substance | ISO | RGD:732757 | 6480464 | PTK2 protein results in decreased susceptibility to Tretinoin | CTD | PMID:16226872 |
| aluminium oxide | multiple interactions | ISO | RGD:732757 | 6480464 | [Aluminum Oxide co-treated with Magnesium] results in increased expression of PTK2 protein | CTD | PMID:12209937 |
| ammonium chloride | decreases expression | ISO | RGD:3443 | 6480464 | Ammonium Chloride results in decreased expression of PTK2 protein | CTD | PMID:16483693 |
| ammonium chloride | affects expression | ISO | RGD:3443 | 6480464 | Ammonium Chloride affects the expression of PTK2 mRNA | CTD | PMID:16483693 |
| arsenic atom | increases phosphorylation | ISO | RGD:732757 | 6480464 | Arsenic results in increased phosphorylation of PTK2 protein | CTD | PMID:18215454 |
| arsenic atom | decreases expression | ISO | RGD:732757 | 6480464 | Arsenic results in decreased expression of PTK2 protein | CTD | PMID:16420308 |
| arsenic atom | decreases phosphorylation | ISO | RGD:3443 | 6480464 | Arsenic results in decreased phosphorylation of PTK2 protein | CTD | PMID:18215454 |
| atropine | multiple interactions | ISO | RGD:732757 | 6480464 | Atropine inhibits the reaction [oxotremorine M inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein]]; more ... | CTD | PMID:10537051 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PTK2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732757 | 6480464 | Benzo(a)pyrene results in decreased expression of PTK2 mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of PTK2 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732757 | 6480464 | Benzo(a)pyrene results in decreased expression of PTK2 mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732757 | 6480464 | Benzo(a)pyrene results in decreased expression of PTK2 mRNA | CTD | PMID:20064835 PMID:20106945 |
| capsaicin | multiple interactions | ISO | RGD:732757 | 6480464 | Capsaicin inhibits the reaction [EGF results in increased phosphorylation of PTK2 protein] | CTD | PMID:21462327 |
| chlorpyrifos | increases expression | ISO | RGD:3443 | 6480464 | Chlorpyrifos results in increased expression of PTK2 mRNA | CTD | PMID:20691718 |
| cisplatin | decreases expression | ISO | RGD:732757 | 6480464 | Cisplatin results in decreased expression of PTK2 mRNA | CTD | PMID:21532991 |
| cisplatin | decreases expression | ISO | RGD:732757 | 6480464 | Cisplatin results in decreased expression of PTK2 mRNA | CTD | PMID:19561079 PMID:21532991 |
| cisplatin | decreases expression | ISO | RGD:3443 | 6480464 | Cisplatin results in decreased expression of PTK2 protein modified form | CTD | PMID:21795690 |
| cisplatin | decreases expression | ISO | RGD:732757 | 6480464 | Cisplatin results in decreased expression of PTK2 protein | CTD | PMID:16391810 |
| cocaine | decreases expression | ISO | RGD:732757 | 6480464 | Cocaine results in decreased expression of PTK2 mRNA | CTD | PMID:12629581 |
| copper atom | multiple interactions | ISO | RGD:3443 | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in decreased phosphorylation of PTK2 protein | CTD | PMID:22276220 |
| copper(0) | multiple interactions | ISO | RGD:3443 | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in decreased phosphorylation of PTK2 protein | CTD | PMID:22276220 |
| D-mannitol | multiple interactions | ISO | RGD:732757 | 6480464 | benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Mannitol results in decreased phosphorylation of and results in increased degradation of PTK2 protein] | CTD | PMID:12011046 |
| daidzein | increases phosphorylation | ISO | RGD:732757 | 6480464 | daidzein results in increased phosphorylation of PTK2 protein | CTD | PMID:12421874 |
| dasatinib (anhydrous) | decreases phosphorylation | ISO | RGD:732757 | 6480464 | dasatinib results in decreased phosphorylation of PTK2 protein | CTD | PMID:20682659 PMID:16740687 |
| dasatinib (anhydrous) | decreases phosphorylation | ISO | RGD:732757 | 6480464 | dasatinib results in decreased phosphorylation of PTK2 protein | CTD | PMID:16740687 PMID:20682659 |
| dibenzo[a,l]pyrene | decreases expression | ISO | RGD:732757 | 6480464 | dibenzo(a,l)pyrene results in decreased expression of PTK2 mRNA | CTD | PMID:16269432 |
| disodium selenite | multiple interactions | ISO | RGD:732757 | 6480464 | Sodium Selenite results in increased phosphorylation of and results in increased activity of PTK2 protein | CTD | PMID:12896980 |
| docetaxel anhydrous | increases cleavage | ISO | RGD:732757 | 6480464 | docetaxel results in increased cleavage of PTK2 protein | CTD | PMID:16361572 |
| doxazosin | decreases expression | ISO | RGD:732757 | 6480464 | Doxazosin results in decreased expression of PTK2 protein | CTD | PMID:15221243 |
| doxorubicin | multiple interactions | ISO | RGD:732757 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PTK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein]] | CTD | PMID:16168102 |
| doxorubicin | decreases phosphorylation | ISO | RGD:3443 | 6480464 | Doxorubicin results in decreased phosphorylation of PTK2 protein | CTD | PMID:16825486 |
| doxorubicin | affects cleavage | ISO | RGD:732757 | 6480464 | Doxorubicin affects the cleavage of PTK2 protein | CTD | PMID:15870702 |
| endosulfan | increases phosphorylation | ISO | RGD:732757 | 6480464 | Endosulfan results in increased phosphorylation of PTK2 protein | CTD | PMID:22677888 |
| gadolinium trichloride | increases activity | ISO | RGD:732757 | 6480464 | gadolinium chloride results in increased activity of PTK2 | CTD | PMID:19184457 |
| geldanamycin | increases degradation | ISO | RGD:732757 | 6480464 | geldanamycin results in increased degradation of PTK2 protein | CTD | PMID:9973544 |
| geldanamycin | decreases phosphorylation | ISO | RGD:732757 | 6480464 | geldanamycin results in decreased phosphorylation of PTK2 protein | CTD | PMID:12811834 |
| geldanamycin | increases degradation | EXP | | 6480464 | geldanamycin results in increased degradation of PTK2 protein | CTD | PMID:9973544 |
| genistein | increases phosphorylation | ISO | RGD:732757 | 6480464 | Genistein results in increased phosphorylation of PTK2 protein | CTD | PMID:12421874 |
| halothane | decreases phosphorylation | ISO | RGD:732757 | 6480464 | Halothane results in decreased phosphorylation of PTK2 protein | CTD | PMID:18215454 |
| heparin | decreases phosphorylation | EXP | | 6480464 | Heparin results in decreased phosphorylation of PTK2 protein | CTD | PMID:18674534 |
| hyaluronic acid | multiple interactions | ISO | RGD:3443 | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of PTK2 protein] | CTD | PMID:23178681 |
| hydrogen peroxide | affects expression | ISO | RGD:732757 | 6480464 | Hydrogen Peroxide affects the expression of PTK2 mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | multiple interactions | ISO | RGD:3443 | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of PTK2 protein] | CTD | PMID:23178681 |
| hydrogen peroxide | decreases phosphorylation | ISO | RGD:3443 | 6480464 | Hydrogen Peroxide results in decreased phosphorylation of PTK2 protein | CTD | PMID:23178681 |
| hydrogen peroxide | increases cleavage | ISO | RGD:732757 | 6480464 | Hydrogen Peroxide results in increased cleavage of PTK2 protein | CTD | PMID:17888894 |
| hydrogen peroxide | multiple interactions | ISO | RGD:732757 | 6480464 | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PTK2 protein] | CTD | PMID:17888894 |
| indomethacin | affects localization | ISO | RGD:732757 | 6480464 | Indomethacin affects the localization of PTK2 protein | CTD | PMID:12037131 |
| indomethacin | decreases phosphorylation | ISO | RGD:732757 | 6480464 | Indomethacin results in decreased phosphorylation of PTK2 protein | CTD | PMID:12037131 |
| indomethacin | multiple interactions | ISO | RGD:732757 | 6480464 | Indomethacin inhibits the reaction [EGF protein affects the localization of PTK2 protein]; more ... | CTD | PMID:12037131 |
| ketamine | decreases expression | ISO | RGD:3443 | 6480464 | Ketamine results in decreased expression of PTK2 mRNA | CTD | PMID:20080153 |
| L-ascorbic acid | decreases expression | ISO | RGD:3443 | 6480464 | Ascorbic Acid results in decreased expression of PTK2 mRNA | CTD | PMID:15372504 |
| lead(0) | decreases phosphorylation | ISO | RGD:3443 | 6480464 | Lead results in decreased phosphorylation of PTK2 protein | CTD | PMID:18215454 |
| luteolin | multiple interactions | ISO | RGD:732757 | 6480464 | EGF protein inhibits the reaction [Luteolin results in decreased phosphorylation of PTK2 protein]; more ... | CTD | PMID:15135307 |
| luteolin | decreases phosphorylation | ISO | RGD:732757 | 6480464 | Luteolin results in decreased phosphorylation of PTK2 protein | CTD | PMID:15135307 |
| LY294002 | multiple interactions | ISO | RGD:732757 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PTK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein]] | CTD | PMID:16168102 |
| lysophosphatidic acid | increases phosphorylation | EXP | | 6480464 | lysophosphatidic acid results in increased phosphorylation of PTK2 protein | CTD | PMID:11792571 |
| lysophosphatidic acid | multiple interactions | ISO | RGD:732757 | 6480464 | Atropine inhibits the reaction [oxotremorine M inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein]] | CTD | PMID:10537051 |
| lysophosphatidic acid | multiple interactions | ISO | RGD:3443 | 6480464 | KNG1 protein inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein] | CTD | PMID:10537051 |
| lysophosphatidic acid | increases phosphorylation | ISO | RGD:732757 | 6480464 | lysophosphatidic acid results in increased phosphorylation of PTK2 protein | CTD | PMID:10537051 |
| lysophosphatidic acid | increases phosphorylation | ISO | RGD:3443 | 6480464 | lysophosphatidic acid results in increased phosphorylation of PTK2 protein | CTD | PMID:10537051 |
| magnesium atom | multiple interactions | ISO | RGD:732757 | 6480464 | [Aluminum Oxide co-treated with Magnesium] results in increased expression of PTK2 protein | CTD | PMID:12209937 |
| methylisothiazolinone | decreases phosphorylation | ISO | RGD:3443 | 6480464 | 2-methyl-4-isothiazolin-3-one results in decreased phosphorylation of PTK2 protein | CTD | PMID:18215454 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:732757 | 6480464 | Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein] | CTD | PMID:17888894 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of PTK2 mRNA | CTD | PMID:12839937 |
| nickel dichloride | multiple interactions | EXP | | 6480464 | HIF1A affects the reaction [nickel chloride results in increased expression of PTK2 mRNA] | CTD | PMID:12729255 |
| nitric oxide | decreases expression | EXP | | 6480464 | Nitric Oxide deficiency results in decreased expression of PTK2 mRNA | CTD | PMID:15878706 |
| oxotremorine M | multiple interactions | ISO | RGD:732757 | 6480464 | Atropine inhibits the reaction [oxotremorine M promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein]]; more ... | CTD | PMID:10537051 |
| oxotremorine M | increases phosphorylation | ISO | RGD:732757 | 6480464 | oxotremorine M results in increased phosphorylation of PTK2 protein | CTD | PMID:10537051 |
| ozone | decreases expression | ISO | RGD:3443 | 6480464 | Ozone results in decreased expression of PTK2 mRNA | CTD | PMID:16330353 |
| paracetamol | decreases expression | ISO | RGD:732757 | 6480464 | Acetaminophen results in decreased expression of PTK2 mRNA | CTD | PMID:22230336 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:3443 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PTK2 mRNA | CTD | PMID:20136073 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:732757 | 6480464 | [oxophenylarsine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PTK2 protein; more ... | CTD | PMID:10569804 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:732757 | 6480464 | Atropine inhibits the reaction [oxotremorine M promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein]]; more ... | CTD | PMID:10537051 |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:732757 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of PTK2 protein | CTD | PMID:10537051 |
| phosgene | affects expression | EXP | | 6480464 | Phosgene affects the expression of PTK2 mRNA | CTD | PMID:16300373 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PTK2 mRNA | CTD | PMID:18301758 |
| poly(vinylpyrrolidone) | multiple interactions | EXP | | 6480464 | [Silver Compounds co-treated with Povidone] results in increased activity of PTK2 protein | CTD | PMID:21729742 |
| quercetin | decreases phosphorylation | ISO | RGD:732757 | 6480464 | Quercetin results in decreased phosphorylation of PTK2 protein | CTD | PMID:15135307 |
| quercetin | multiple interactions | ISO | RGD:732757 | 6480464 | EGF protein inhibits the reaction [Quercetin results in decreased phosphorylation of PTK2 protein]; more ... | CTD | PMID:15135307 |
| resveratrol | decreases phosphorylation | ISO | RGD:732757 | 6480464 | resveratrol results in decreased phosphorylation of PTK2 protein | CTD | PMID:12421874 |
| resveratrol | affects localization | ISO | RGD:732757 | 6480464 | resveratrol affects the localization of PTK2 protein | CTD | PMID:21467134 |
| resveratrol | multiple interactions | ISO | RGD:732757 | 6480464 | resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of PTK2 protein] | CTD | PMID:21467134 |
| resveratrol | decreases expression | ISO | RGD:732757 | 6480464 | resveratrol results in decreased expression of PTK2 protein; more ... | CTD | PMID:18089832 |
| resveratrol | increases phosphorylation | ISO | RGD:732757 | 6480464 | resveratrol results in increased phosphorylation of PTK2 protein | CTD | PMID:12421874 |
| rosiglitazone | decreases phosphorylation | ISO | RGD:732757 | 6480464 | rosiglitazone results in decreased phosphorylation of PTK2 protein | CTD | PMID:16775433 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | EXP | | 6480464 | Buthionine Sulfoximine results in increased expression of PTK2 mRNA | CTD | PMID:15878706 |
| silver atom | increases phosphorylation | ISO | RGD:3443 | 6480464 | Silver results in increased phosphorylation of PTK2 protein | CTD | PMID:11341783 |
| silver(0) | increases phosphorylation | ISO | RGD:3443 | 6480464 | Silver results in increased phosphorylation of PTK2 protein | CTD | PMID:11341783 |
| simvastatin | decreases activity | ISO | RGD:732757 | 6480464 | Simvastatin results in decreased activity of PTK2 protein | CTD | PMID:17428261 |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of PTK2 protein | CTD | PMID:19922502 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of PTK2 mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:732757 | 6480464 | tert-Butylhydroperoxide results in decreased expression of PTK2 mRNA | CTD | PMID:15336504 |
| testosterone | increases phosphorylation | ISO | RGD:732757 | 6480464 | Testosterone results in increased phosphorylation of PTK2 protein | CTD | PMID:16038899 |
| testosterone | multiple interactions | ISO | RGD:732757 | 6480464 | wortmannin inhibits the reaction [Testosterone results in increased phosphorylation of PTK2 protein] | CTD | PMID:16038899 |
| tetrathiomolybdate(2-) | multiple interactions | ISO | RGD:3443 | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in decreased phosphorylation of PTK2 protein | CTD | PMID:22276220 |
| thimerosal | increases response to substance | ISO | RGD:732757 | 6480464 | PTK2 protein results in increased susceptibility to Thimerosal | CTD | PMID:17888894 |
| thimerosal | multiple interactions | ISO | RGD:732757 | 6480464 | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; more ... | CTD | PMID:17888894 |
| trans-resveratrol | decreases phosphorylation | ISO | RGD:732757 | 6480464 | resveratrol results in decreased phosphorylation of PTK2 protein | CTD | PMID:12421874 |
| trans-resveratrol | affects localization | ISO | RGD:732757 | 6480464 | resveratrol affects the localization of PTK2 protein | CTD | PMID:21467134 |
| trans-resveratrol | multiple interactions | ISO | RGD:732757 | 6480464 | resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of PTK2 protein] | CTD | PMID:21467134 |
| trans-resveratrol | decreases expression | ISO | RGD:732757 | 6480464 | resveratrol results in decreased expression of PTK2 protein; more ... | CTD | PMID:18089832 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:732757 | 6480464 | resveratrol results in increased phosphorylation of PTK2 protein | CTD | PMID:12421874 |
| uranium atom | affects expression | ISO | RGD:732757 | 6480464 | Uranium affects the expression of PTK2 mRNA | CTD | PMID:15672453 |
| wortmannin | multiple interactions | ISO | RGD:732757 | 6480464 | wortmannin inhibits the reaction [Testosterone results in increased phosphorylation of PTK2 protein] | CTD | PMID:16038899 |
| wortmannin | multiple interactions | ISO | RGD:3443 | 6480464 | KNG1 protein inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein]; more ... | CTD | PMID:10537051 |
| wortmannin | multiple interactions | ISO | RGD:732757 | 6480464 | Atropine inhibits the reaction [oxotremorine M inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein]]; more ... | CTD | PMID:10537051 |
| zoledronic acid | decreases phosphorylation | ISO | RGD:732757 | 6480464 | zoledronic acid results in decreased phosphorylation of PTK2 protein | CTD | PMID:12933798 |
| zoledronic acid | increases expression | ISO | RGD:732757 | 6480464 | zoledronic acid results in increased expression of PTK2 mRNA | CTD | PMID:20977926 |